Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06064461 · ClinicalTrials.gov registry record
Vitaccess Real MG Registry
A clinical trial of Myasthenia Gravis, sponsored by Vitaccess.
- Recruiting
- Registry status
- 600
- Enrollment target
- 8
- Study locations
NCT06064461: Recruiting study of Myasthenia Gravis, sponsored by Vitaccess.
NCT06064461 is a study of Myasthenia Gravis that is actively recruiting participants, run by Vitaccess. The registered enrollment target is 600 participants, above the 172-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (249% higher). The trial reports 8 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06064461, a study of Myasthenia Gravis, is actively recruiting participants, sponsored by Vitaccess.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 8
- Study locations
Study Summary
Vitaccess Real MG (VRMG) is a patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 600 patients will be recruited in the US and Europe with no defined upper limit. The registry will link relevant patient- and healthcare professional (HCP)-reported data with clinical data from medical records. Patients will be recruited at clinical sites in all participating countries. In the US only, patients can additionally be recruited via community neurologists or direct-to-patient recruitment.
Primary Outcome
A patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life.
Conditions Studied
Study Locations (8)
California
- UCI Health - Orange
Illinois
- HSHS St. Elizabeth's Hospital - O'Fallon
Kentucky
- UK HealthCare - University of Kentucky - Lexington
New Jersey
- Neurology Associates of South Jersey - Lumberton
South Carolina
- Medical University South Carolina - Charleston
Texas
- University of Texas Health Science Center at Houston - Houston
London
- Vitaccess Ltd - London
Other
- University Hospitals Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-07-31 |
| Est. Completion | 2034-07 |
What NCT06064461 shows while recruiting
NCT06064461 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 172-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (249% higher).
The record links to 1 condition, with Myasthenia Gravis appearing as the primary indexed condition, and to 0 interventions.
NCT06064461 lists 8 locations in 8 states (California, Illinois, Kentucky).
Frequently Asked Questions
What is clinical trial NCT06064461 about?
NCT06064461 is a clinical study titled "Vitaccess Real MG Registry". Vitaccess Real MG (VRMG) is a patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 600 patients will ...
What is the current status of trial NCT06064461?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2024-07-31. Estimated completion is 2034-07.
What conditions does trial NCT06064461 study?
This clinical trial studies the following conditions: Myasthenia Gravis.
Who is sponsoring clinical trial NCT06064461?
This trial is sponsored by Vitaccess, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06064461 being conducted?
This trial has 8 study locations across California, Illinois, Kentucky, New Jersey, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myasthenia Gravis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06064461's enrollment target sits among peer trials
600 4th of 32 higher than 29 of 32 other Myasthenia Gravis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myasthenia Gravis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
RECRUITING
-
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
RECRUITING · Phase 3
-
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
RECRUITING
-
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI